Interleukin-4 Receptor alpha Antagonist [EPC]

518489 reported adverse events

Drugs of this class: DUPILUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-4 Receptor alpha Antagonist [EPC] class:

# Side effect Count
0 PRURITUS 65143
1 DERMATITIS ATOPIC 48270
2 PRODUCT USE IN UNAPPROVED INDICATION 44555
3 RASH 41246
4 INJECTION SITE PAIN 40378
5 DRUG INEFFECTIVE 32504
6 DRY SKIN 28839
7 ECZEMA 28786
8 PRODUCT DOSE OMISSION ISSUE 25576
9 CONDITION AGGRAVATED 21742
See all common reactions for Interleukin-4 Receptor alpha Antagonist [EPC]

Drugs of the Interleukin-4 Receptor alpha Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND ATOPIC DERMATITIS 2002 0.9965
1 REBOUND ECZEMA 2020 0.9858
2 DERMATITIS ATOPIC 48270 0.9145
3 EOSINOPHILIC OESOPHAGITIS 2025 0.7305
4 NEURODERMATITIS 2593 0.6959
5 EXPOSURE VIA SKIN CONTACT 16495 0.6359
6 SKIN WEEPING 2192 0.6138
7 EYELID SKIN DRYNESS 688 0.5672
8 ECZEMA 28786 0.5495
9 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7754 0.4561
See all enriched reactions for Interleukin-4 Receptor alpha Antagonist [EPC]